ALB and breast carcinoma: 1 ku molecular weight donkey serum albumin peptides, produced by hydrolysis, have been demonstrated to inhibited cell proliferation in human leukemia, liver cancer and breast cancer cells, suggesting these molecules may be of therapeutic interest in the context of cancer treatment.